Foundry Partners LLC Invests $3.57 Million in Envista Holdings Co. (NYSE:NVST)

Foundry Partners LLC acquired a new stake in Envista Holdings Co. (NYSE:NVST) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 148,437 shares of the company’s stock, valued at approximately $3,571,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of NVST. Alliance Wealth Advisors LLC UT lifted its holdings in Envista by 6.3% in the third quarter. Alliance Wealth Advisors LLC UT now owns 8,295 shares of the company’s stock worth $231,000 after purchasing an additional 490 shares during the period. Fifth Third Bancorp lifted its stake in shares of Envista by 98.1% in the 4th quarter. Fifth Third Bancorp now owns 1,254 shares of the company’s stock worth $30,000 after acquiring an additional 621 shares during the period. Covestor Ltd boosted its holdings in shares of Envista by 33.9% in the third quarter. Covestor Ltd now owns 2,462 shares of the company’s stock valued at $69,000 after acquiring an additional 624 shares in the last quarter. Arizona State Retirement System increased its stake in shares of Envista by 1.4% during the third quarter. Arizona State Retirement System now owns 46,611 shares of the company’s stock valued at $1,300,000 after acquiring an additional 635 shares during the period. Finally, Oppenheimer Asset Management Inc. raised its holdings in Envista by 3.5% during the third quarter. Oppenheimer Asset Management Inc. now owns 20,459 shares of the company’s stock worth $570,000 after purchasing an additional 698 shares in the last quarter.

Envista Stock Performance

Envista stock opened at $20.13 on Tuesday. Envista Holdings Co. has a 52 week low of $18.95 and a 52 week high of $39.28. The company has a quick ratio of 1.90, a current ratio of 2.23 and a debt-to-equity ratio of 0.33. The company has a 50 day moving average price of $21.12 and a 200 day moving average price of $22.84.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.04). The business had revenue of $645.60 million for the quarter, compared to analyst estimates of $638.37 million. Envista had a negative net margin of 3.90% and a positive return on equity of 6.31%. The firm’s quarterly revenue was down 2.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.52 earnings per share. On average, equities analysts forecast that Envista Holdings Co. will post 1.43 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Jefferies Financial Group lowered Envista from a “buy” rating to a “hold” rating and decreased their price target for the company from $30.00 to $23.00 in a research note on Friday, February 9th. TheStreet lowered Envista from a “c” rating to a “d+” rating in a report on Wednesday, February 7th. UBS Group initiated coverage on shares of Envista in a research report on Friday, January 5th. They set a “neutral” rating and a $26.00 price objective for the company. William Blair lowered shares of Envista from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 8th. Finally, SVB Leerink assumed coverage on Envista in a research report on Monday, February 26th. They set an “underperform” rating and a $19.00 price objective for the company. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $29.60.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.